Endoscopic submucosal dissection for early Barrett's neoplasia: a meta-analysis

D Yang, F Zou, S Xiong, JJ Forde, Y Wang… - Gastrointestinal …, 2018 - Elsevier
Background and Aims The role of endoscopic submucosal dissection (ESD) in Barrett's
esophagus (BE) is not well established. This meta-analysis aimed to evaluate the safety and …

Endoscopic submucosal dissection for Barrett's early neoplasia: a multicenter study in the United States

D Yang, RM Coman, M Kahaleh, I Waxman… - Gastrointestinal …, 2017 - Elsevier
Background and Aims The role of endoscopic submucosal dissection (ESD) in Barrett's early
neoplasia is not well defined, with most studies originating from Asia and Europe. We aimed …

Extending treatment criteria for Barrett's neoplasia: Results of a nationwide cohort of 138 endoscopic submucosal dissection procedures

SN van Munster, EPD Verheij, EA Nieuwenhuis… - …, 2022 - thieme-connect.com
Background The use of endoscopic submucosal dissection (ESD) is gradually expanding for
treatment of neoplasia in Barrett's esophagus (BE). We aimed to report outcomes of all ESDs …

Endoscopic submucosal dissection vs. endoscopic mucosal resection for early Barrett's neoplasia in the West: a retrospective study

LKM Perez, D Yang, PV Draganov, S Jawaid… - …, 2022 - thieme-connect.com
Background The difference in clinical outcomes after endoscopic submucosal dissection
(ESD) and endoscopic mucosal resection (EMR) for early Barrett's esophagus (BE) …

Clinical outcome in patients treated with endoscopic submucosal dissection for superficial Barrett's neoplasia

JB Chevaux, H Piessevaux, A Jouret-Mourin… - …, 2015 - thieme-connect.com
Background and study aims: The role of endoscopic submucosal dissection (ESD) in
Barrett's neoplasia is ill-defined, although it might provide a higher curative resection rate …

Complex early Barrett's neoplasia at 3 Western centers: European Barrett's endoscopic submucosal dissection trial (E-BEST)

S Subramaniam, F Chedgy… - Gastrointestinal …, 2017 - Elsevier
Background and Aims Endoscopic submucosal dissection (ESD) is an effective technique to
resect early Barrett's neoplasia and has advantages over conventional EMR in that it …

A randomised trial of endoscopic submucosal dissection versus endoscopic mucosal resection for early Barrett's neoplasia

G Terheggen, EM Horn, M Vieth, H Gabbert, M Enderle… - Gut, 2017 - gut.bmj.com
Background For endoscopic resection of early GI neoplasia, endoscopic submucosal
dissection (ESD) achieves higher rates of complete resection (R0) than endoscopic mucosal …

Prospective evaluation of the clinical utility of endoscopic submucosal dissection (ESD) in patients with Barrett's esophagus: a Western center experience

RM Coman, T Gotoda, CE Forsmark… - Endoscopy …, 2016 - thieme-connect.com
Background and study aims: Endoscopic submucosal dissection (ESD) carries significant
advantages over endoscopic mucosal resection. As such, ESD is an established therapy for …

Effect of endoscopic submucosal dissection on histologic diagnosis in Barrett's esophagus visible neoplasia

D Yang, W King, H Aihara, MS Karasik… - Gastrointestinal …, 2022 - Elsevier
Background and Aims Data are limited on the role of endoscopic submucosal dissection
(ESD) as a potential diagnostic and staging tool in Barrett's esophagus (BE) neoplasia. We …

Endoscopic submucosal dissection is associated with less pathologic uncertainty than endoscopic mucosal resection in diagnosing and staging Barrett's‐related …

A Podboy, KS Kolahi, S Friedland… - Digestive …, 2020 - Wiley Online Library
Background & Aims Endoscopic mucosal resection (EMR) and endoscopic submucosal
dissection (ESD) have demonstrated similar efficacy in removal of neoplastic esophageal …